Videos

Pharmacy specialists discuss quality initiatives in MPN management by sharing advice on assessing symptoms and patient adherence.

Just making sure that everybody has a seat at the table is the most important thing at PQA.

PQA wants to expand the types of services covered and report on the results of the current examples that are profiled in the SDOH guide.

The challenges in pharmacy are really a lack of standardization.

Pharmacists are ideally positioned to screen patients for estimation aids and then refer them to services.

Pharmacists are an important touch point for PQA, and they're starting small and thinking big.

Linaclotide (Linzess) is indicated in adults for treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.

PQA is also committed to national goals related to HIV and reducing HIV ending the epidemic.

PQA is focused on actually testing the feasibility and implementation of some of these measures as concepts.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how the use of artificial intelligence may help develop new drug therapies targeting multiple disease states.

Karen Fancher, PharmD, BCOP, a member of the Patient Advisory Panel at the Hematology/Oncology Pharmacy Association (HOPA), explains how her experience as a patient with cancer and an oncology pharmacy specialist informs her work on HOPA’s Patient Advisory Panel.

Byron Yoshino, PharmD, CEO of Pharmacare Hawaii, discusses the future of the home infusion space within the United States in the coming years.

Sara Wettergreen, assistant professor in the department of Clinical Pharmacy, and Department of Family Medicine, at Skaggs School of Pharmacy and Pharmaceutical Sciences, on burnout and mental health concerns among pharmacy technicians

Without sufficient vitamin D exposure, bones can become thin, brittle, or misshapen; however, excessive amounts of vitamin D are toxic.

Dong Xu, PhD, MS, curators' distinguished professor at the University of Missouri College of Engineering, discusses how artificial intelligence is being used to develop new drug therapies for medical treatments targeting cancers and other diseases.

One example that has already been done in the past relates to understanding how to better measure insulin persistence.

Byron Yoshino, PharmD, CEO of Pharmacare Hawaii, discusses the rapidly growing home infusion space within Pharmacare Hawaii’s network of pharmacies.

Issues like medication access and transportation cost all impact a patient's ability to have access to medications and use them safely and effectively.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses whether patient out of pocket costs rose in 2021, and what the implications may be for the health care system and for patients in 2022.

It's really opening up the world for pharmacists to develop more meaningful measures and get at patient reported and clinical outcome measures.

It's extremely important for pharmacists to be involved in helping care for people who have HIV.

Murray Aitken, executive director of IQVIA Institute for Human Data Science, discusses the implications of the increase in spending on medicines in the United States in 2021.

Galcanezumab-gnlm (Emgality) is a CGRP antagonist indicated in adults for the preventive treatment of migraine and treatment of episodic cluster headache.

Experts in MPN care discuss the importance and impact of patient education while managing myeloproliferative neoplasms.

Pharmacy experts detail their decision-making processes while selecting treatment for myeloproliferative neoplasms and monitoring patients on therapy.

Pharmacy performance measures allow the pharmacy to be more engaged in the patient's care that focuses on outcomes.

There are many initiatives that are going on at PQA right now that are related to health equity.

Ibalizumab-uiyk (Trogarzo, Theratechnologies) is an injectable CD4-directed post-attachment HIV-1 inhibitor for the treatment of HIV type 1 infection in heavily treatment-experienced adults.

The guide is an opportunity to just catalog what else is going on there to kind of be an inspiration for expansion of services.

Agnieszka Sekula and Prash Puspanathan, MD, co-founders of Enosis Therapeutics, discuss the impact of therapeutic environment on the pharmaceutical effects of psychedelics.